PERSPECTA

News from every angle

← Back to headlines

OptimizeRx Beats Q1 Earnings and Revenue Forecasts

OptimizeRx announced Non-GAAP EPS of $0.14, exceeding estimates by $0.14, and revenue of $19.84 million, which beat projections by $1.49 million.

12 May, 20:17 — 12 May, 20:17
PostShare

Sources

Showing 1 of 1 sources
seeking-alphaMixed2h ago

OptimizeRx Non-GAAP EPS of $0.14 beats by $0.14, revenue of $19.84M beats by $1.49M

Read full article →

Related Stories

Oil Jumps Above $100 After US-Iran Talks Fail

just now

Cadre Projects Strong 2026 Sales and Record Backlog

21m ago

Market Analysts Find Silver Lining in 5% Treasury Yields

21m ago

Federal Agricultural Mortgage to raise $100M via 6.875% preferred stock offering

28m ago